Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Abortion

CLI Responds to New Guttmacher Report showing Decline in Abortion Rate & Number of Abortions

 

In response to the latest Guttmacher Institute report released today, the Charlotte Lozier Institute issued the following comment:

 

 

 “We welcome the new report showing the decline in both the abortion rate and the overall number of abortions from 2011 to 2017. There are several reasons for this positive news, including factors that Guttmacher does their best to ignore. American mothers are increasingly choosing life for their children, as well as choosing to identify themselves with the pro-life cause and pro-life policies. This includes the broad protections for women and children being enacted at the state level such as strengthened health and safety standards for abortion facilities, limits on public funding of abortion, parental involvement laws, and increased informed consent,” said Chuck Donovan, president of the Charlotte Lozier Institute.

 

“The rise in so-called medication abortion should concern us all as it reveals the abortion industry’s increasingly successful effort to cut the overhead costs of surgical abortion while still profiting off the destruction of unborn children and wounding of his or her mother, who is given dangerous abortion drugs and then sent off to pass the body of her aborted child in isolation. The industry’s migration to chemical self-abortion is deeply disturbing as it carries with it the possibility of increasing the overall abortion rate over time and also carries with it a higher rate of injury, about which women are often under informed or deceived.”

 

Regarding chemical abortion, CLI experts have previously criticized flawed research purporting to show that self-administered, self-reported chemical abortions are not dangerous to women.

 

AbortionDrugFacts.com, a new website developed with input from CLI’s team of experts and pro-life partners, aims to give women the information they need to protect their health and safety before they go through a chemical abortion, to have a second chance to change their mind after initiating one or to recover from the trauma they may already have experienced as a result of taking abortion drugs. In addition, the site provides women who have been hurt by the abortion pill an opportunity to share their story and/or make a confidential report to the FDA.

 

CLI Scholars Tessa Longbons, an expert on state abortion reporting, and Dr. Michael New, Ph. D., an expert on the impact of pro-life laws, are available for further comment and analysis on this topic.

Latest Posts

April 17, 2024 Fact Sheet: Planned Parenthood’s 2022-23 Annual Report April 10, 2024 New Study: Abortion Increases Risk of Cardiovascular Diseases New Study: Abortion Increases Risk of Cardiovascular Diseases April 2, 2024 Abortion Reporting: Florida (2023)

You Might Also Be Interested In

Fact Sheet: Planned Parenthood’s 2022-23 Annual Report

charlotte-lozier-institute Charlotte Lozier Institute
April 17, 2024
ClosePlease login
New Study: Abortion Increases Risk of Cardiovascular Diseases

New Study: Abortion Increases Risk of Cardiovascular Diseases

charlotte-lozier-institute Charlotte Lozier Institute
April 10, 2024
ClosePlease login

Abortion Reporting: Florida (2023)

April 2, 2024
ClosePlease login

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image